Global Transcriptomics 麻豆原创 2025 by Company, Regions, Type and Application, Forecast to 2031

Publication ID:

GIR072509332

Publication Date:

July 22, 2025

Pages:

Publisher:

GIR

Countries:

Global [1]

USD 3,480.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Transcriptomics market size was valued at US$ 4693 million in 2024 and is forecast to a readjusted size of USD 8948 million by 2031 with a CAGR of 9.8% during review period.
Transcriptomic incorporates the exploration and assortment of transcriptomes and finds diverse applications, chiefly in molecular genetics. The global transcriptomic market could see a whole lot of instances of new product launch. For example, Trio RNA-Seq launched by NuGEN Technologies, Inc. is particularly suited for low abundance transcripts applications as it offers an extremely sensitive whole transcriptomic solution. This innovation embodies three powerful technologies, viz. single primer isothermal amplification (SPIA), DimerFree, and AnyDeplete, for performing high sensitivity ribonucleic acid (RNA) analysis.
North America is the largest consumption place, with a consumption market share nearly 55% . Following North America, Europe is the second largest consumption place with the consumption market share of 25% .The key manufacturers are Thermo Fisher Scientific, Illumina, QIAGEN (Exiqon), Agilent Technologies, Roche, GE Healthcare, Bio-Rad Laboratories, Fluidigm etc. Top 3 companies occupied about 41% market share.
This report is a detailed and comprehensive analysis for global Transcriptomics market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Transcriptomics market size and forecasts, in consumption value ($ Million), 2020-2031
Global Transcriptomics market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
Global Transcriptomics market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
Global Transcriptomics market shares of main players, in revenue ($ Million), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Transcriptomics
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Transcriptomics market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Thermo Fisher Scientific, Illumina, QIAGEN (Exiqon), Agilent Technologies, Roche, GE Healthcare, Bio-Rad Laboratories, Fluidigm, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
麻豆原创 segmentation
Transcriptomics market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
麻豆原创 segment by Type
PCR
Microarray
Sequencing
麻豆原创 segment by Application
Pharmaceutical and Biotechnology
Academic Research and Government Institutes
Hospitals and Diagnostic Centers
麻豆原创 segment by players, this report covers
Thermo Fisher Scientific
Illumina
QIAGEN (Exiqon)
Agilent Technologies
Roche
GE Healthcare
Bio-Rad Laboratories
Fluidigm
麻豆原创 segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Transcriptomics product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Transcriptomics, with revenue, gross margin, and global market share of Transcriptomics from 2020 to 2025.
Chapter 3, the Transcriptomics competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Transcriptomics market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Transcriptomics.
Chapter 13, to describe Transcriptomics research findings and conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.

Table Of Contents:

1 麻豆原创 Overview
1.1 Product Overview and Scope
1.2 麻豆原创 Estimation Caveats and Base Year
1.3 Classification of Transcriptomics by Type
1.3.1 Overview: Global Transcriptomics 麻豆原创 Size by Type: 2020 Versus 2024 Versus 2031
1.3.2 Global Transcriptomics Consumption Value 麻豆原创 Share by Type in 2024
1.3.3 PCR
1.3.4 Microarray
1.3.5 Sequencing
1.4 Global Transcriptomics 麻豆原创 by Application
1.4.1 Overview: Global Transcriptomics 麻豆原创 Size by Application: 2020 Versus 2024 Versus 2031
1.4.2 Pharmaceutical and Biotechnology
1.4.3 Academic Research and Government Institutes
1.4.4 Hospitals and Diagnostic Centers
1.5 Global Transcriptomics 麻豆原创 Size & Forecast
1.6 Global Transcriptomics 麻豆原创 Size and Forecast by Region
1.6.1 Global Transcriptomics 麻豆原创 Size by Region: 2020 VS 2024 VS 2031
1.6.2 Global Transcriptomics 麻豆原创 Size by Region, (2020-2031)
1.6.3 North America Transcriptomics 麻豆原创 Size and Prospect (2020-2031)
1.6.4 Europe Transcriptomics 麻豆原创 Size and Prospect (2020-2031)
1.6.5 Asia-Pacific Transcriptomics 麻豆原创 Size and Prospect (2020-2031)
1.6.6 South America Transcriptomics 麻豆原创 Size and Prospect (2020-2031)
1.6.7 Middle East & Africa Transcriptomics 麻豆原创 Size and Prospect (2020-2031)
2 Company Profiles
2.1 Thermo Fisher Scientific
2.1.1 Thermo Fisher Scientific Details
2.1.2 Thermo Fisher Scientific Major Business
2.1.3 Thermo Fisher Scientific Transcriptomics Product and Solutions
2.1.4 Thermo Fisher Scientific Transcriptomics Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.1.5 Thermo Fisher Scientific Recent Developments and Future Plans
2.2 Illumina
2.2.1 Illumina Details
2.2.2 Illumina Major Business
2.2.3 Illumina Transcriptomics Product and Solutions
2.2.4 Illumina Transcriptomics Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.2.5 Illumina Recent Developments and Future Plans
2.3 QIAGEN (Exiqon)
2.3.1 QIAGEN (Exiqon) Details
2.3.2 QIAGEN (Exiqon) Major Business
2.3.3 QIAGEN (Exiqon) Transcriptomics Product and Solutions
2.3.4 QIAGEN (Exiqon) Transcriptomics Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.3.5 QIAGEN (Exiqon) Recent Developments and Future Plans
2.4 Agilent Technologies
2.4.1 Agilent Technologies Details
2.4.2 Agilent Technologies Major Business
2.4.3 Agilent Technologies Transcriptomics Product and Solutions
2.4.4 Agilent Technologies Transcriptomics Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.4.5 Agilent Technologies Recent Developments and Future Plans
2.5 Roche
2.5.1 Roche Details
2.5.2 Roche Major Business
2.5.3 Roche Transcriptomics Product and Solutions
2.5.4 Roche Transcriptomics Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.5.5 Roche Recent Developments and Future Plans
2.6 GE Healthcare
2.6.1 GE Healthcare Details
2.6.2 GE Healthcare Major Business
2.6.3 GE Healthcare Transcriptomics Product and Solutions
2.6.4 GE Healthcare Transcriptomics Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.6.5 GE Healthcare Recent Developments and Future Plans
2.7 Bio-Rad Laboratories
2.7.1 Bio-Rad Laboratories Details
2.7.2 Bio-Rad Laboratories Major Business
2.7.3 Bio-Rad Laboratories Transcriptomics Product and Solutions
2.7.4 Bio-Rad Laboratories Transcriptomics Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.7.5 Bio-Rad Laboratories Recent Developments and Future Plans
2.8 Fluidigm
2.8.1 Fluidigm Details
2.8.2 Fluidigm Major Business
2.8.3 Fluidigm Transcriptomics Product and Solutions
2.8.4 Fluidigm Transcriptomics Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.8.5 Fluidigm Recent Developments and Future Plans
3 麻豆原创 Competition, by Players
3.1 Global Transcriptomics Revenue and Share by Players (2020-2025)
3.2 麻豆原创 Share Analysis (2024)
3.2.1 麻豆原创 Share of Transcriptomics by Company Revenue
3.2.2 Top 3 Transcriptomics Players 麻豆原创 Share in 2024
3.2.3 Top 6 Transcriptomics Players 麻豆原创 Share in 2024
3.3 Transcriptomics 麻豆原创: Overall Company Footprint Analysis
3.3.1 Transcriptomics 麻豆原创: Region Footprint
3.3.2 Transcriptomics 麻豆原创: Company Product Type Footprint
3.3.3 Transcriptomics 麻豆原创: Company Product Application Footprint
3.4 New 麻豆原创 Entrants and Barriers to 麻豆原创 Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 麻豆原创 Size Segment by Type
4.1 Global Transcriptomics Consumption Value and 麻豆原创 Share by Type (2020-2025)
4.2 Global Transcriptomics 麻豆原创 Forecast by Type (2026-2031)
5 麻豆原创 Size Segment by Application
5.1 Global Transcriptomics Consumption Value 麻豆原创 Share by Application (2020-2025)
5.2 Global Transcriptomics 麻豆原创 Forecast by Application (2026-2031)
6 North America
6.1 North America Transcriptomics Consumption Value by Type (2020-2031)
6.2 North America Transcriptomics 麻豆原创 Size by Application (2020-2031)
6.3 North America Transcriptomics 麻豆原创 Size by Country
6.3.1 North America Transcriptomics Consumption Value by Country (2020-2031)
6.3.2 United States Transcriptomics 麻豆原创 Size and Forecast (2020-2031)
6.3.3 Canada Transcriptomics 麻豆原创 Size and Forecast (2020-2031)
6.3.4 Mexico Transcriptomics 麻豆原创 Size and Forecast (2020-2031)
7 Europe
7.1 Europe Transcriptomics Consumption Value by Type (2020-2031)
7.2 Europe Transcriptomics Consumption Value by Application (2020-2031)
7.3 Europe Transcriptomics 麻豆原创 Size by Country
7.3.1 Europe Transcriptomics Consumption Value by Country (2020-2031)
7.3.2 Germany Transcriptomics 麻豆原创 Size and Forecast (2020-2031)
7.3.3 France Transcriptomics 麻豆原创 Size and Forecast (2020-2031)
7.3.4 United Kingdom Transcriptomics 麻豆原创 Size and Forecast (2020-2031)
7.3.5 Russia Transcriptomics 麻豆原创 Size and Forecast (2020-2031)
7.3.6 Italy Transcriptomics 麻豆原创 Size and Forecast (2020-2031)
8 Asia-Pacific
8.1 Asia-Pacific Transcriptomics Consumption Value by Type (2020-2031)
8.2 Asia-Pacific Transcriptomics Consumption Value by Application (2020-2031)
8.3 Asia-Pacific Transcriptomics 麻豆原创 Size by Region
8.3.1 Asia-Pacific Transcriptomics Consumption Value by Region (2020-2031)
8.3.2 China Transcriptomics 麻豆原创 Size and Forecast (2020-2031)
8.3.3 Japan Transcriptomics 麻豆原创 Size and Forecast (2020-2031)
8.3.4 South Korea Transcriptomics 麻豆原创 Size and Forecast (2020-2031)
8.3.5 India Transcriptomics 麻豆原创 Size and Forecast (2020-2031)
8.3.6 Southeast Asia Transcriptomics 麻豆原创 Size and Forecast (2020-2031)
8.3.7 Australia Transcriptomics 麻豆原创 Size and Forecast (2020-2031)
9 South America
9.1 South America Transcriptomics Consumption Value by Type (2020-2031)
9.2 South America Transcriptomics Consumption Value by Application (2020-2031)
9.3 South America Transcriptomics 麻豆原创 Size by Country
9.3.1 South America Transcriptomics Consumption Value by Country (2020-2031)
9.3.2 Brazil Transcriptomics 麻豆原创 Size and Forecast (2020-2031)
9.3.3 Argentina Transcriptomics 麻豆原创 Size and Forecast (2020-2031)
10 Middle East & Africa
10.1 Middle East & Africa Transcriptomics Consumption Value by Type (2020-2031)
10.2 Middle East & Africa Transcriptomics Consumption Value by Application (2020-2031)
10.3 Middle East & Africa Transcriptomics 麻豆原创 Size by Country
10.3.1 Middle East & Africa Transcriptomics Consumption Value by Country (2020-2031)
10.3.2 Turkey Transcriptomics 麻豆原创 Size and Forecast (2020-2031)
10.3.3 Saudi Arabia Transcriptomics 麻豆原创 Size and Forecast (2020-2031)
10.3.4 UAE Transcriptomics 麻豆原创 Size and Forecast (2020-2031)
11 麻豆原创 Dynamics
11.1 Transcriptomics 麻豆原创 Drivers
11.2 Transcriptomics 麻豆原创 Restraints
11.3 Transcriptomics Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 Industry Chain Analysis
12.1 Transcriptomics Industry Chain
12.2 Transcriptomics Upstream Analysis
12.3 Transcriptomics Midstream Analysis
12.4 Transcriptomics Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer

Companies Mentioned:

Thermo Fisher Scientific
Illumina
QIAGEN (Exiqon)
Agilent Technologies
Roche
GE Healthcare
Bio-Rad Laboratories
Fluidigm

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.